Code Story | Eduardo Abeliuk, Teselagen
July 18, 2023
Eduardo Abeliuk is a Chilean physicist and electrical engineer who built an enterprise solution for R&D projects with colleagues from Stanford.
Teselagen’s AI Enabled Operating System for Biotechnology
June 1, 2023
Dr. Eduardo Abeliuk discusses TeselaGen Biotech’s mission, biotech trends, digitalization, and future wishes for advancements in AI and its impact on daily life.
Dr. Eduardo Abeliuk Strives To Make the World a Better Place by Develop Technologies that Will Help Us Push the Evolution of Our Species and of Our Universe
May 26, 2023
Welcome to another episode of The Action and Ambition Podcast! Joining us today is Dr. Eduardo Abeliuk, a U.S.-based entrepreneur and technologist with over twenty years of experience driving technology development and innovation at various high-tech companies in the US.
Future in Review (FiRe) – “Tools for Building the Synthetic Biology-Based Economy”
July 11, 2022
Our CEO and founder of Teselagen, Eduardo Abeliuk, presented a webinar on Teselagen’s Design and Build Platform, and introduced us to its applications.
AI-4-EB – “Enabling Tools and Algorithms for Speeding Up SynBio workflows”
March 25, 2022
Our CEO and founder of Teselagen, Eduardo Abeliuk, presented a webinar on Teselagen’s Design and Build Platform, and introduced us to its applications.
TedX Santa Barbara: Hot-rodding Cells & AI for Building Drugs – An Interview with Mike Fero, PhD
October 6, 2021
TeselaGen founder, president and COO Mike Fero, PhD, had the opportunity to speak with Mark Sylvester, host of Making Waves Conversations on TedX Santa Barbara.
iGEM Academy: Introduction to Teselagen’s Design and Build Platform
September 16, 2021
Our CEO and founder of Teselagen, Eduardo Abeliuk, presented a webinar on Teselagen’s Design and Build Platform, and introduced us to its applications.
Featured on CABTalk: AI, Life Science, and Wraparound Care with Mike Fero COO of TeselaGen
August 5, 2021
With advancements in artificial intelligence and cloud computing technologies, there are a growing number of solutions in Computer-Aided Biology. But what exactly are the problems? We speak with Dr Mike Fero, the former CEO and current COO of TeselaGen – one of the first big AI companies in the Computer-Aided Biology, on the problems facing scientists and how CAB companies should be articulating that problem.
“Full Steam Ahead!” – taking synthetic biology to the high throughput era
November 13, 2020
Taking synthetic biology to the high throughput era “Synthetic Biology continues to move forward at speed, enabled by the iterative cycle of ‘Design-Build-Test-Learn’ (DBTL) for
Optimize Your Workflow: Bottlenecks and Solutions in the Design, Build, & Test Phases.
November 6, 2020
Learn how to optimize your the synthetic biology workflow brought to you by Beckman Coulter and synbiobeta. Learn from industry leaders what are the bottlenecks & solutions in the Design, Build & Phase.